254040 National Release of the Leading Health Indicators from Healthy People 2020

Monday, October 31, 2011: 10:30 AM

Howard Koh, MD, MPH , Assistant Secretary for Health, Office of Public Health and Science, US Department of Health and Human Services, Washington, DC
The Assistant Secretary for Health and public health officials will unveil the leading health indicators (LHIs) during a press conference event for media and Healthy People stakeholders. The leading health indicators have been developed to communicate high-priority health issues to the public, and actions that can be taken to address them. Based on a Health Determinants and Health Outcomes by Life Stages framework, as well as input from public and Federal groups, the indicators will be used to assess the health of the US population over the decade, to facilitate collaboration among diverse groups, and to motivate individuals and communities to take action to improve their health.

Learning Areas:
Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Public health administration or related administration

Learning Objectives:
Identify and describe the 12 priority topics from Healthy People 2020, and the 25 leading health indicators organized under those topics. Assess an LHI topic based on the Health Determinants and Health Outcomes by Life Stages framework. Differentiate between high-priority and lower-priority public health issues in a given community, based on the LHIs.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I manage the Healthy People Initiative and I oversee this office. We will announce the Healthy People 2020 Leading Health Indicators that will help communicate high-priority health issues to the public and actions that can be taken to address them.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.